ArticleBMC health services research2025
Implementation of multiparameter point-of-care testing devices for non-communicable diseases at primary healthcare level in Peru.
Article in BMC health services research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPoint-of-care testing (POCT) devices are a potential solution to improving access to faster and more accurate diagnosis of non-communicable diseases (NCDs), particularly in resource-limited settings. However, evidence about their implementation in low- and middle- income countries is limited.
aimTo determine the potential utility of a co-created strategy for implementing multiparameter POCT devices to improve care for three NCDs at public primary healthcare centres in urban and rural areas in Tumbes, Peru.
methodsThis quasi-experimental cluster trial with a concurrent control was conducted in Tumbes, Peru. This study compared the current standard of care (conventional testing) to POCT in the screening and monitoring of certain NCDs (type 2 diabetes, kidney disease, and hypercholesterolemia) among patients at the primary healthcare level. The diagnosis was based on Peruvian clinical practice guidelines for NCDs. The intervention consisted of training for health professionals, implementing a POCT device in the laboratory for three months, advertising the population about the availability of this new device, and three months of follow-up care for participants. Relative risk (RR) was estimated.
results1,234 participants were recruited in eight facilities. 37.8% of participants received a new diagnosis. Using POCT alone significantly increased the diagnosis of new diabetes cases (adjusted relative risk [aRR]: 1.84) and high cholesterol detection (aRR: 1.24) compared to conventional testing. The combination of POCT plus conventional testing showed even greater increases in diabetes (aRR: 2.42) and high cholesterol diagnoses (aRR: 1.56) compared to control sites.
conclusionsThe use of POCT significantly increased the diagnosis of diabetes and high cholesterol compared to conventional laboratory testing. This suggests that POCT may be an effective tool for increased early detection of NCDs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.